XML 66 R44.htm IDEA: XBRL DOCUMENT v2.4.0.6
Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2012
Fair Value Disclosures [Abstract]  
Summary of assets and liabilities recorded at fair value
(In millions)
As of
December 31,
2012
 
Quoted
Prices in
Active
Markets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Assets:
 
 
 
 
 
 
 
Cash equivalents
$
439.4

 
$

 
$
439.4

 
$

Marketable debt securities:
 
 
 
 
 
 
 
Corporate debt securities
1,001.0

 

 
1,001.0

 

Government securities
1,657.8

 

 
1,657.8

 

Mortgage and other asset backed securities
512.9

 

 
512.9

 

Marketable equity securities
9.0

 
9.0

 

 

Venture capital investments
20.3

 

 

 
20.3

Derivative contracts
1.8

 

 
1.8

 

Plan assets for deferred compensation
14.3

 

 
14.3

 

Total
$
3,656.5

 
$
9.0

 
$
3,627.2

 
$
20.3

Liabilities:
 
 
 
 
 
 
 
Derivative contracts
$
14.4

 
$

 
$
14.4

 
$

Contingent consideration obligations
293.9

 

 

 
293.9

Total
$
308.3

 
$

 
$
14.4

 
$
293.9

(In millions)
As of
December 31,
2011
 
Quoted
Prices
in Active
Markets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Assets:
 
 
 
 
 
 
 
Cash equivalents
$
399.8

 
$

 
$
399.8

 
$

Marketable debt securities:
 
 
 
 
 
 
 
Corporate debt securities
602.6

 

 
602.6

 

Government securities
1,716.5

 

 
1,716.5

 

Mortgage and other asset backed securities
273.8

 

 
273.8

 

Marketable equity securities
0.1

 
0.1

 

 

Venture capital investments
23.5

 

 

 
23.5

Derivative contracts
39.5

 

 
39.5

 

Plan assets for deferred compensation
11.6

 

 
11.6

 

Total
$
3,067.4

 
$
0.1

 
$
3,043.8

 
$
23.5

Liabilities:
 
 
 
 
 
 
 
Derivative contracts
$
0.5

 
$

 
$
0.5

 
$

Contingent consideration obligations
151.0

 

 

 
151.0

Total
$
151.5

 
$

 
$
0.5

 
$
151.0

Fair value of venture capital investments
 
As of December 31,
(In millions)
2012
 
2011
Fair value, beginning of year
$
23.5

 
$
20.8

Unrealized gains included in earnings
5.4

 
2.4

Unrealized losses included in earnings
(9.2
)
 
(1.4
)
Purchases
0.6

 
1.7

Fair value, end of year
$
20.3

 
$
23.5

Summary of fair and carrying value of debt instruments
 
As of December 31,
(In millions)
2012
 
2011
Notes payable to Fumedica
$
20.0

 
$
22.4

6.0% Senior Notes due March 1, 2013
453.7

 
474.1

6.875% Senior Notes due March 1, 2018
681.6

 
663.9

Total
$
1,155.3

 
$
1,160.4

Fair value of contingent consideration obligations
 
As of December 31,
(In millions)
2012
 
2011
Fair value, beginning of year
$
151.0

 
$
81.2

Additions
122.2

 
38.8

Changes in fair value
27.2

 
36.0

Payments
(6.5
)
 
(5.0
)
Fair value, end of year
$
293.9

 
$
151.0